NUS Stock Overview
Engages in the development and distribution of various beauty and wellness products worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Nu Skin Enterprises, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$7.16 |
| 52 Week High | US$24.08 |
| 52 Week Low | US$6.72 |
| Beta | 1.12 |
| 11 Month Change | -26.03% |
| 3 Month Change | -42.44% |
| 1 Year Change | -69.98% |
| 33 Year Change | -82.65% |
| 5 Year Change | -83.26% |
| Change since IPO | -75.10% |
Recent News & Updates
Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business
Aug 31
Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price
Aug 13Recent updates
Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business
Aug 31Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price
Aug 13Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year
May 30Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?
May 13Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal
Mar 28Nu Skin: A Sell Signal Amidst Industry Decline And Strategic Uncertainty
Mar 04We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings
Feb 22Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06
Feb 19Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically
Feb 18Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks
Jan 18Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet
Dec 14Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39
Nov 17Nu Skin: Is It Just A Growth Problem?
Oct 17Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company
Oct 09When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?
Sep 27Nu Skin: Attractive Valuation Trumps Near-Term Risks
Sep 12Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt
Sep 08Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39
Aug 05Is Nu Skin Enterprises, Inc. (NYSE:NUS) Expensive For A Reason? A Look At Its Intrinsic Value
Jul 31Nu Skin: A High-Risk/High-Reward Turnaround Play Worth The Risks
Jun 26Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?
Jun 23We Think Nu Skin Enterprises (NYSE:NUS) Is Taking Some Risk With Its Debt
May 22Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.39
May 07Nu Skin Enterprises (NYSE:NUS) Could Be Struggling To Allocate Capital
Apr 26Why Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Worth Watching
Mar 18Nu Skin Enterprises (NYSE:NUS) Will Pay A Larger Dividend Than Last Year At $0.39
Feb 19Nu Skin raises quarterly dividend by 1.3% to $0.39/share
Feb 15These 4 Measures Indicate That Nu Skin Enterprises (NYSE:NUS) Is Using Debt Reasonably Well
Feb 12Returns On Capital At Nu Skin Enterprises (NYSE:NUS) Paint A Concerning Picture
Jan 25Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?
Dec 04Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.385
Nov 17Shareholder Returns
| NUS | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -5.4% | 2.3% | 1.0% |
| 1Y | -70.0% | -14.8% | 27.6% |
Return vs Industry: NUS underperformed the US Personal Products industry which returned -14.8% over the past year.
Return vs Market: NUS underperformed the US Market which returned 27.6% over the past year.
Price Volatility
| NUS volatility | |
|---|---|
| NUS Average Weekly Movement | 8.1% |
| Personal Products Industry Average Movement | 8.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: NUS's share price has been volatile over the past 3 months.
Volatility Over Time: NUS's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 3,700 | Ryan Napierski | www.nuskin.com |
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+.
Nu Skin Enterprises, Inc. Fundamentals Summary
| NUS fundamental statistics | |
|---|---|
| Market cap | US$363.82m |
| Earnings (TTM) | -US$148.46m |
| Revenue (TTM) | US$1.84b |
0.2x
P/S Ratio-2.4x
P/E RatioIs NUS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NUS income statement (TTM) | |
|---|---|
| Revenue | US$1.84b |
| Cost of Revenue | US$532.17m |
| Gross Profit | US$1.31b |
| Other Expenses | US$1.46b |
| Earnings | -US$148.46m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.99 |
| Gross Margin | 71.14% |
| Net Profit Margin | -8.05% |
| Debt/Equity Ratio | 66.8% |
How did NUS perform over the long term?
See historical performance and comparison